Meningococcal Disease Vaccine Market is Valued at USD 6.60 Billion with a CAGR of 10.0% by 2029 Meningococcal Disease Vaccine Market Analysis and Size
Meningococcal disease is an uncommon infection caused by the bacteria Neisseria meningitidis that affects the lining of the brain, spinal cord, and blood. The germs that cause meningococcal disease transmit by saliva or spit, usually through direct contact with sick persons and subsequent contact.
Meningococcal septicemia occurs when...
0 Compartilhamentos
3058 Visualizações
0 Anterior